{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:13:59Z","timestamp":1792826039729,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejphar.2019.01.044","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T18:19:50Z","timestamp":1548440390000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The relatively selective cyclooxygenase-2 inhibitor nimesulide: What\u2019s going on?"],"prefix":"10.1016","volume":"848","author":[{"given":"Elisabetta","family":"Caiazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ialenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cicala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.01.044_bib1","article-title":"Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis","author":"Afzal","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2019.01.044_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2010.07.006","article-title":"Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis","volume":"644","author":"Al-Abd","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ibd.20316","article-title":"Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases","volume":"14","author":"Antonioli","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2019.01.044_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pharmthera.2008.08.010","article-title":"Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications","volume":"120","author":"Antonioli","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.01.044_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2019.01.044_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.drudis.2014.02.010","article-title":"Adenosine and inflammation: what's new on the horizon?","volume":"19","author":"Antonioli","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2019.01.044_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1538\/expanim.15-0122","article-title":"Effects of nimesulide on the small intestine mucositis induced by methotrexate in rats","volume":"65","author":"Arslan","year":"2016","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejphar.2019.01.044_bib8","first-page":"1859","article-title":"COX-2 inhibitors compared and contrasted","volume":"11","author":"Bennett","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2019.01.044_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2007.04.058","article-title":"Indomethacin stimulates activity and expression of ecto-5\u2032-nucleotidase\/CD73 in glioma cell lines","volume":"569","author":"Bernardi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.01.044_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2165\/00003495-199300461-00009","article-title":"Recent contributions to knowledge of the mechanism of action of nimesulide","volume":"46","author":"Bevilacqua","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.01.044_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0922-4106(94)90067-1","article-title":"Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV","volume":"268","author":"Bevilacqua","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2019.01.044_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0024-3205(02)02338-X","article-title":"Effect of nimesulide on gastric acid secretion in the mouse stomach in vitro","volume":"72","author":"Borrelli","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.01.044_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2016.05.006","article-title":"Adenosine signaling mediates the anti-inflammatory effects of the COX-2 inhibitor nimesulide","volume":"112","author":"Caiazzo","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.phrs.2008.03.003","article-title":"Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences","volume":"57","author":"Candelario-Jalil","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2019.01.044_bib16","first-page":"992","article-title":"Inhibition of neutrophil function in vitro by nimesulide","volume":"43","author":"Capecchi","year":"1993","journal-title":"Prelim. Evid. Aden.-Mediat. Mech. Arzneim."},{"key":"10.1016\/j.ejphar.2019.01.044_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.prostaglandins.2006.05.019","article-title":"Pharmacodynamic of cyclooxygenase inhibitors in humans","volume":"82","author":"Capone","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2019.01.044_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01974932","article-title":"Inhibition of neutrophil oxidative metabolism by nimesulide","volume":"21","author":"Capsoni","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejphar.2019.01.044_bib19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(25)39405-X","article-title":"Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells","volume":"267","author":"Casolaro","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.01.044_bib20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF03261999","article-title":"Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)","volume":"35","author":"Castellsague","year":"2012","journal-title":"Drug Saf."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.01.044_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2165\/00003495-199300461-00010","article-title":"Antipyretic and platelet antiaggregating effects of nimesulide","volume":"46","author":"Ceserani","year":"1993","journal-title":"Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.01.044_bib22","first-page":"S5S","article-title":"Mechanisms of action of methotrexate","author":"Chan","year":"2013","journal-title":"Bull. Hosp. Jt. Dis."},{"key":"10.1016\/j.ejphar.2019.01.044_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejphar.2013.06.033","article-title":"Adenosine signaling in airways: toward a promising antiasthmatic approach","volume":"714","author":"Cicala","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib24","first-page":"824","article-title":"Recombinant secreted non pancreatic phospholipase A2 induces a synovitis-like inflammation in the rat air pouch","volume":"21","author":"Cirino","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib25","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ejphar.2019.01.044_bib26","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1073\/pnas.88.6.2441","article-title":"Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells","volume":"88","author":"Cronstein","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2019.01.044_bib27","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2019.01.044_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF01534273","article-title":"Non steroidal anti-inflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms","volume":"18","author":"Cronstein","year":"1994","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2019.01.044_bib29","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.96.11.6377","article-title":"Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NF kappa B","volume":"96","author":"Cronstein","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.01.044_bib30","first-page":"15","article-title":"Are there any differences among non-steroidal anti-inflammatory drugs? Focus on nimesulide","author":"Dallegri","year":"2007","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejphar.2019.01.044_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000196365","article-title":"The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migration across monolayers of cytokine-activated endothelial cells","volume":"61","author":"Dapino","year":"1994","journal-title":"Respiration"},{"key":"10.1016\/j.ejphar.2019.01.044_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00003495-199448030-00008","article-title":"Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"48","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.01.044_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/bcp.12938","article-title":"Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy","volume":"82","author":"Donati","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib34","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.4049\/jimmunol.178.12.8127","article-title":"Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury","volume":"178","author":"Eckle","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.1711340205","article-title":"The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system","volume":"134","author":"Edwards","year":"1981","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib36","unstructured":"European Medicines Agency, 2012. Assessment report for nimesulide containing medicinal products for systemic use. Procedure number: EMA\/73856\/2012."},{"key":"10.1016\/j.ejphar.2019.01.044_bib37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/joca.2000.0393","article-title":"Nimesulide reduces interleukin-1beta-induced cyclooxygenase-2 gene expression in human synovial fibroblasts","volume":"9","author":"Fahmi","year":"2001","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejphar.2019.01.044_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s000110050221","article-title":"In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview","volume":"46","author":"Famaey","year":"1997","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2019.01.044_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/2042098617690485","article-title":"Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications","volume":"8","author":"Fanelli","year":"2017","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.ejphar.2019.01.044_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bcp.2010.04.033","article-title":"Role of eicosanoids on intestinal epithelial homeostasis","volume":"15","author":"Ferrer","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib41","article-title":"Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases","author":"Ferrer","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.01.044_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"Fitzgerald","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.01.044_bib43","first-page":"51","article-title":"Survey on appropriateness of use of nimesulide in nine European countries","volume":"7","author":"Franchi","year":"2015","journal-title":"Drug Healthc. Patient Saf."},{"key":"10.1016\/j.ejphar.2019.01.044_bib44","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","article-title":"Adenosine, an endogenous distress signal, modulates tissue damage and repair","volume":"14","author":"Fredholm","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2019.01.044_bib45","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.4049\/jimmunol.156.5.1937","article-title":"The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites","volume":"156","author":"Gadangi","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj2330309","article-title":"Extracellular ATP: effects, sources and fate","volume":"233","author":"Gordon","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2019.01.044_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.49.3.443","article-title":"Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives","volume":"49","author":"Halter","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2019.01.044_bib48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bmj.300.6720.278","article-title":"Non-steroidal anti-inflammatory drugs and peptic ulcers","volume":"300","author":"Hawkey","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2019.01.044_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/jpet.117.244319","article-title":"Adenosine A(2A) receptor agonist,2-p-(2-Carboxyethyl)phenethylamino-5\u2032-N-ethylcarboxamidoadenosine hydrochloride hydrate, inhibits inflammation and increases fibroblast growth factor-2 tissue expression in carrageenan-induced rat paw edema","volume":"364","author":"Ialenti","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.01.044_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2019.01.044_bib51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.10055","article-title":"Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism","volume":"46","author":"Kalajdzic","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2019.01.044_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00535-009-0028-8","article-title":"Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats","volume":"44","author":"Koizumi","year":"2009","journal-title":"J. Gastroenterol."},{"issue":"Suppl","key":"10.1016\/j.ejphar.2019.01.044_bib53","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0885-3924(02)00629-2","article-title":"Gastrointestinal effects of NSAIDs and coxibs","volume":"2","author":"Laine","year":"2003","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.ejphar.2019.01.044_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.RES.0000069022.95401.FE","article-title":"Hypoxia enhances Ecto-5\u2032-Nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids","volume":"92","author":"Ledoux","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.01.044_bib55","article-title":"Aspirin-induced acute gastric mucosal injury is a neutrophil-dependent process in rats","author":"Lee","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2009.04.017","article-title":"Inhibitory effect of non steroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells","volume":"612","author":"Li","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2008.10.028","article-title":"Nimesulide inhibits IFN-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells by COX-2 and PGE2 independent mechanisms","volume":"276","author":"Liang","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.01.044_bib58","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.77.5.2551","article-title":"Subclasses of external adenosine receptors","volume":"77","author":"Londos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.01.044_bib59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199300461-00004","article-title":"The effect of nimesulide on prostanoid formation","volume":"46","author":"Magni","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.01.044_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00126839-200506050-00002","article-title":"Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis","volume":"6","author":"Manicourt","year":"2005","journal-title":"Drugs RD"},{"key":"10.1016\/j.ejphar.2019.01.044_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/abbi.2001.2439","article-title":"Role of Ca2+-independent phospholipase A2 on arachidonic acid release induced by reactive oxygen species","volume":"392","author":"Mart\u00ednez","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2019.01.044_bib62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002280100312","article-title":"Fatal hepatoxicity secondary to nimesulide","volume":"57","author":"Merlani","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib63","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjp.0702897","article-title":"Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy","volume":"128","author":"Mitchell","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs","volume":"5","author":"Mitchell","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2019.01.044_bib65","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bcp.2012.07.017","article-title":"The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention\/treatment of high prevalence diseases.","volume":"84","author":"Mitjavila","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib66","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1529-0131(200003)43:3<656::AID-ANR23>3.0.CO;2-H","volume":"43","author":"Montesinos","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2019.01.044_bib67","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5\u2032-nucleotidase: findings in a study of ecto-5\u2032-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2019.01.044_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2016.12.004","article-title":"Eicosanoid receptors: targets for the treatment of disrupted intestinal epithelial homeostasis","volume":"796","author":"Moreno","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib69","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.172.3.1646","article-title":"IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5\u2032-nucleotidase) up-regulation","volume":"172","author":"Niemel\u00e4","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib70","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/eji.200838437","article-title":"IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier","volume":"38","author":"Niemel\u00e4","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2005.05.032","article-title":"Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease","volume":"129","author":"Odashima","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2019.01.044_bib72","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3748\/wjg.v12.i4.568","article-title":"Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats","volume":"28","author":"Odashima","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.01.044_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-199300461-00007","article-title":"Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes","author":"Ottonello","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.01.044_bib74","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.annfar.2008.04.023","article-title":"Acute liver failure due to a treatment by nimesulide: another case and review","volume":"27","author":"Page","year":"2008","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.ejphar.2019.01.044_bib75","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.bjp.0707524","article-title":"Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction","volume":"153","author":"Palmer","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib76","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/art.1780400313","article-title":"Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of anti-inflammatory and immunosuppressive drugs","volume":"40","author":"de Paulis","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2019.01.044_bib77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10787-006-1505-9","article-title":"Current status of the therapeutic uses and actions of the preferential cyclooxygenase-2 NSAID, nimesulide","volume":"14","author":"Rainsford","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2019.01.044_bib78","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1185\/030079906X104849","article-title":"Nimesulide - a multifactorial approach to inflammation and pain: scientific and clinical consensus","volume":"22","author":"Rainsford","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2019.01.044_bib79","doi-asserted-by":"crossref","first-page":"e0190509","DOI":"10.1371\/journal.pone.0190509","article-title":"Drug repurposing: in-vitro anti-glycation properties of 18 common drugs","volume":"13","author":"Rasheed","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.01.044_bib80","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1096\/fj.08-119701","article-title":"Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs","volume":"23","author":"Reutershan","year":"2009","journal-title":"FASEB J."},{"issue":"Suppl. S29\u2013S34","key":"10.1016\/j.ejphar.2019.01.044_bib81","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2019.01.044_bib82","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1078-0432.CCR-0902-03","article-title":"Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma","volume":"10","author":"Shaik","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.01.044_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1098-8823(03)00038-8","article-title":"Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats","volume":"71","author":"Singh","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2019.01.044_bib84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000079135","article-title":"Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats","volume":"72","author":"Singh","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2019.01.044_bib85","first-page":"255","article-title":"Effect of nimesulide on the indomethacin- and ibuprofen-induced ulcer in rat gastric tissue","volume":"54","author":"S\u00fcleyman","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib86","first-page":"247","article-title":"Anti-inflammatory and side effects of cyclooxygenase inhibitors","volume":"59","author":"S\u00fcleyman","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2019.01.044_bib87","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/092986708783497247","article-title":"Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug","volume":"15","author":"S\u00fcleyman","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.01.044_bib88","series-title":"Anti-Inflammatory and Anti-Rheumatic Drugs. Volume III: Anti-Rheumatic Drugs, Experimental Agents, and Clinical Aspects Of Drug Use","first-page":"105","article-title":"Anti-inflammatory activity of antioxidants","author":"Swingle","year":"1985"},{"key":"10.1016\/j.ejphar.2019.01.044_bib89","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2019.01.044_bib90","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3748\/wjg.v18.i18.2147","article-title":"Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility","volume":"18","author":"Takeuchi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib91","first-page":"141s","article-title":"The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils","volume":"22","author":"Tool","year":"1996","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.ejphar.2019.01.044_bib92","first-page":"1110","article-title":"Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate","volume":"45","author":"Tool","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2019.01.044_bib93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.327.7405.18","article-title":"Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs","volume":"327","author":"Traversa","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2019.01.044_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01630479","article-title":"New insights into the mode of action of anti-inflammatory drugs","volume":"44","author":"Vane","year":"1995","journal-title":"Inflamm. Res."},{"issue":"3 Pt 1","key":"10.1016\/j.ejphar.2019.01.044_bib95","first-page":"G462","article-title":"Gastric ulceration induced by non steroidal anti-inflammatory drugs is a neutrophil-dependent process","volume":"259","author":"Wallace","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib96","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.bjp.0702420","article-title":"Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-air pouch inflammation","volume":"126","author":"Wallace","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.044_bib97","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-6147(98)01283-8","article-title":"Selective COX-2 inhibitors: is the water becoming muddy?","volume":"20","author":"Wallace","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2019.01.044_bib98","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2019.01.044_bib99","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2019.01.044_bib100","first-page":"4888","article-title":"Mitogen-inducible prostaglandin G\/H synthase: a new target for non steroidal anti-inflammatory drugs","volume":"89","author":"Xie","year":"1992","journal-title":"Drug Dev. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:25:14Z","timestamp":1757975114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991930069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":100,"alternative-id":["S001429991930069X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.044","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relatively selective cyclooxygenase-2 inhibitor nimesulide: What\u2019s going on?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}